Gene · 9376
Papers2,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oligomerization of drug transporters: Forms, functions, and mechanisms. | Acta Pharm Sin B | 2024 | 38799641 | PubTator, text mining | PubMed |
| Topotecan and Ginkgolic Acid Inhibit the Expression and Transport Activity of Human Organic Anion Transporter 3 by Suppressing SUMOylation of the Transporter. | Pharmaceutics | 2024 | 38794300 | PubTator, text mining | PubMed |
| Distinguishing Molecular Properties of OAT, OATP, and MRP Drug Substrates by Machine Learning. | Pharmaceutics | 2024 | 38794254 | PubTator, text mining | PubMed |
| Metabolism, Disposition, Excretion, and Potential Transporter Inhibition of 7-16, an Improving 5-HT2A Receptor Antagonist and Inverse Agonist for Parkinson's Disease. | Molecules | 2024 | 38792047 | PubTator, text mining | PubMed |
| Contribution of human organic anion transporter 3-mediated transport of a major linezolid metabolite, PNU-142586, in linezolid-induced thrombocytopenia. | Biomed Pharmacother | 2024 | 38781867 | PubTator, text mining | PubMed |
Risk of Enzyme- and Transporter-mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews. | Clin Ther | 2024 | 38734524 | PubTator, text mining | PubMed |
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group. | Drug Metab Dispos | 2024 | 38697852 | PubTator, text mining | PubMed |
| Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake? | Pharmaceuticals (Basel) | 2024 | 38675472 | PubTator, text mining | PubMed |
| Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors. | Chemosphere | 2024 | 38663675 | PubTator, text mining | PubMed |
| Indoxyl sulphate-TNFα axis mediates uremic encephalopathy in rodent acute kidney injury. | Acta Pharmacol Sin | 2024 | 38589687 | PubTator, text mining | PubMed |
| Preface to Special Issue: Drug Transporters: Regulation and Roles in Therapeutic Strategies. | Pharmaceutics | 2024 | 38543319 | PubTator, text mining | PubMed |
| Dysregulation of the mRNA Expression of Human Renal Drug Transporters by Proinflammatory Cytokines in Primary Human Proximal Tubular Epithelial Cells. | Pharmaceutics | 2024 | 38399338 | PubTator, text mining | PubMed |
| Alkaloid uptake pathways in renal tubular epithelial cells from different processed products of Phellodendri chinensis Cortex. | J Pharm Biomed Anal | 2024 | 38367517 | PubTator, text mining | PubMed |
| Identification and characterization of an endogenous biomarker of the renal vectorial transport (OCT2-MATE1). | Biopharm Drug Dispos | 2024 | 38305087 | PubTator, text mining | PubMed |
| Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use. | BMC Pharmacol Toxicol | 2024 | 38303016 | PubTator, text mining | PubMed |
| Dose-dependent exposure to indoxyl sulfate alters AHR signaling, sirtuins gene expression, oxidative DNA damage, and bone mineral status in rats. | Sci Rep | 2024 | 38297036 | PubTator, text mining | PubMed |
| A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants. | J Pharmacol Exp Ther | 2024 | 38296646 | PubTator, text mining | PubMed |
| Editorial: Transporters: a hitchhiker's guide to physiology, toxicology, and pharmacology-TransportDays 2022. | Front Pharmacol | 2024 | 38288437 | PubTator, text mining | PubMed |
| The Kidney-Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression. | Metabolites | 2024 | 38276313 | PubTator, text mining | PubMed |
| Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice. | Viruses | 2024 | 38275962 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9376/papers?page=6